6th Feb 2007 07:01
ReGen Therapeutics PLC06 February 2007 ReGen Therapeutics PLC6 February 2007 ReGen Therapeutics Plc places 151,841,668 shares ReGen Therapeutics Plc ("ReGen" or the "Company") announces that it has placedthrough its brokers, HB Corporate, with new and existing shareholders151,841,668 new ordinary shares at 0.75p per share to raise £1,138,812.51,before expenses ("Placing"). Application will be made for these 151,841,668 new ordinary shares to beadmitted to the AIM Market of the London Stock Exchange Plc and dealings areexpected to commence at 8am on 9 February 2007. Executive Chairman Percy Lomax commented, "This money will be used for thecontinuing development of the Company's programmes in nutraceuticalColostrinin(TM), zolpidem and the Colostrinin(TM) peptides for pharmaceuticaluse." All new ordinary shares will rank pari passu with the existing ordinary sharesof 0.1p each in the Company. Five of the Company's directors are subscribing for new ordinary shares in theplacing: Mr Percy Lomax is subscribing for 341,667 new ordinary shares makinghis total holding 2,623,736 ordinary shares, representing 0.31% of the enlargedshare capital. Mr Timothy Shilton is subscribing for 666,667 new ordinary sharesmaking his total holding 1,166,667 ordinary shares, representing 0.14% of theenlarged share capital. Mr Martin Small is subscribing for 333,333 new ordinaryshares making his total holding 2,581,333 ordinary shares, representing 0.31% ofthe enlarged share capital. Mr Keith Corbin is subscribing for 666,667 newordinary shares making his total holding 1,771,667 ordinary shares, representing0.21% of the enlarged share capital. Dr Peter Garrod is subscribing for5,000,000 new ordinary shares making his total holding 71,750,000 ordinaryshares representing 8.48% of the enlarged share capital. For further information, please contact: Andrew MarshallGreycoat CommunicationsTel. 020 7960 6007Mobile 07785 297111 Rod Venables/Cecil JordaanHB CorporateTel. 020 7510 8600 Percy LomaxReGen TherapeuticsTel. 020 7907 0910 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
TILS.L